The U.S. Food and Drug Administration on Monday granted full approval of Moderna’s Spikevax COVID vaccine for people 18 and older. Similar to the agency’s licensing last year of Pfizer’s Comirnaty vaccine, the approval raised a number of legal questions.
top of page
To see this working, head to your live site.
1368. FDA Grants Full Approval of Moderna’s Spikevax COVID Vaccine — Another ‘Bait-and-Switch?’
1368. FDA Grants Full Approval of Moderna’s Spikevax COVID Vaccine — Another ‘Bait-and-Switch?’
0 comments
Like
Comments (0)
Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page